Complete remission of an early-stage laryngeal cancer under combined pembrolizumab and chemotherapy treatment of a synchronous lung adenocarcinoma
Background Anti-PD1-Checkpoint inhibition (CI) is an established treatment of recurrent and/or metastatic head and neck cancer. A potential benefit from CI in early-stage disease that is usually treated by radiation or surgery has not been investigated so far and is currently not addressed in clinic...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SAGE Publishing
2022-01-01
|
| Schriftenreihe: | Journal of Otolaryngology - Head and Neck Surgery |
| Online-Zugang: | https://doi.org/10.1186/s40463-022-00572-y |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|